Baricitinib: a review of pharmacology, safety, and emerging clinical experience in COVID‐19

SCJ Jorgensen, CLY Tse, L Burry… - … : The Journal of …, 2020 - Wiley Online Library
A hyperinflammatory response to severe acute respiratory syndrome‐coronavirus 2 (SARS‐
CoV‐2) infection, reminiscent of cytokine release syndrome, has been implicated in the …

[HTML][HTML] Sepsis and septic shock: current treatment strategies and new approaches

G Polat, RA Ugan, E Cadirci, Z Halici - The Eurasian journal of …, 2017 - ncbi.nlm.nih.gov
Sepsis is a complex condition characterized by the simultaneous activation of inflammation
and coagulation in response to microbial insult. These events manifest as systemic …

Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding

KN Iskander, MF Osuchowski… - Physiological …, 2013 - journals.physiology.org
Sepsis represents the host's systemic inflammatory response to a severe infection. It causes
substantial human morbidity resulting in hundreds of thousands of deaths each year …

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

RP Dellinger, MM Levy, JM Carlet, J Bion… - Critical care …, 2008 - journals.lww.com
Objective: To provide an update to the original Surviving Sepsis Campaign clinical
management guidelines,“Surviving Sepsis Campaign Guidelines for Management of Severe …

The pathophysiology and treatment of sepsis

RS Hotchkiss, IE Karl - New England journal of medicine, 2003 - Mass Medical Soc
Sepsis is the leading cause of death in critically ill patients in the United States. Yet the
individual host response to septicemia is variable, depending on the patient's immune …

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

RP Dellinger, JM Carlet, H Masur, H Gerlach… - Critical care …, 2004 - journals.lww.com
Objective In 2003, critical care and infectious disease experts representing 11 international
organizations developed management guidelines for severe sepsis and septic shock that …

Corticosteroids as adjunctive therapy in the treatment of influenza

L Lansbury, C Rodrigo, J Leonardi‐Bee… - Cochrane Database …, 2019 - cochranelibrary.com
Background Specific treatments for influenza are limited to neuraminidase inhibitors and
adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions …

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

D Annane, VÚ SÚbille, C Charpentier, PE Bollaert… - Jama, 2002 - jamanetwork.com
ContextSeptic shock may be associated with relative adrenal insufficiency. Thus, a
replacement therapy of low doses of corticosteroids has been proposed to treat septic shock …

Hydrocortisone therapy for patients with septic shock

CL Sprung, D Annane, D Keh, R Moreno… - … England Journal of …, 2008 - Mass Medical Soc
Background Hydrocortisone is widely used in patients with septic shock even though a
survival benefit has been reported only in patients who remained hypotensive after fluid and …

Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis

SL Rygård, E Butler, A Granholm, MH Møller… - Intensive care …, 2018 - Springer
Purpose To assess the effect of low dose corticosteroids on outcomes in adults with septic
shock. Methods We systematically reviewed randomised clinical trials (RCTs) comparing …